Pohjois-Savon Sairaanhoitopiirin Kuntayhtyma

Pohjois-Savon Sairaanhoitopiirin Kuntayhtyma is a research organisation in Kys, Finland that has taken part in 10 EU-funded projects since 2013, receiving €3.1M in EU funding and leading 1 as coordinator.

EU funding received€3.1M
EU projects10
As coordinator1
Running now1
First EU project2013
Latest project2022
CountryFinland
EU registration (PIC)998250766
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Pohjois-Savon Sairaanhoitopiirin Kuntayhtyma's own share of each project, not the project's full budget.

  • Horizon 2020€2.7M · 8 projects
  • FP7 (2007 to 2013)€347k · 1 project
  • Horizon Europe€0 · 1 project

Projects

10 EU-funded projects, newest first. Pohjois-Savon Sairaanhoitopiirin Kuntayhtyma led 1 of them as coordinator. Each links to the official record.

  • Eyes4ICUAssociated partner

    Eyes for Information, Communication, and Understanding

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

  • SLEEP REVOLUTIONPartner

    Revolution of sleep diagnostics and personalized health care based on digital diagnostics and therapeutics with health data integration

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  • CardioReGenixPartner

    CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €678ktheir share
  • euCanSHareAssociated partner

    An EU-Canada joint infrastructure for next-generation multi-Study Heart research

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  • MIRACLEPartner

    Mid-infrared arthroscopy innovative imaging system for real-time clinical in depth examination and diagnosis of degenerative joint diseases

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €123ktheir share
  • ReGenHeartCoordinator

    Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina A phase II randomized, double-blinded, placebo-controlled study

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €1.5Mtheir share
  • ChiLTERNPartner

    Children’s Liver Tumour European Research Network

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €20ktheir share
  • INEXCAPartner

    Excellent research and expertise of quality of cancer care by internationally trained staff

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €54ktheir share
  • WOMEN-UPPartner

    Cost effective self-management of urinary incontinence addressed to women across Europe

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €362ktheir share
  • COSMOPHOS-NANOPartner

    Novel nanotechnology-enabled system for endovascular in vivo near-infrared fluorescence molecular imaging and endovascular near-infrared targeted photodynamic therapy of atherosclerotic heart disease

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €347ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • cardiology
  • cardiovascular diseases
  • cryptography
  • data processing
  • eHealth
  • economics
  • gene therapy
  • hepatology
  • history
  • laser physics
  • liver cancer
  • mobile phones
  • nanomedicine
  • nuclear medicine

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime